Skip to main content
Clinical Trials/CTRI/2024/07/070853
CTRI/2024/07/070853
Not yet recruiting
Phase 2

Evaluation of effectiveness of individualized homoeopathic medicine on quality of life in patients on hemo-dialysis in end stage kidney disease: a placebo control study. - NI

Dr Anil Vishnu Paradkar0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Anil Vishnu Paradkar
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr Anil Vishnu Paradkar

Eligibility Criteria

Inclusion Criteria

  • Clinically diagnosed cases of End Stage Kidney Disease on Hemodialysisfrom both the sex of all socio\-economic status
  • Patients of End Stage Kidney Disease on Hemodialysis with comorbidities of Diabetes Mellites, Hypertension, Cardiovascular Diseases.
  • Patients of End Stage Kidney Disease on Hemodialysis for at least 3Months.

Exclusion Criteria

  • End Stage Kidney Disease Patients taking treatment for any other systemic disorder except morbidities leading to End Stage Kidney Disease

Outcomes

Primary Outcomes

Not specified

Similar Trials